US Physical Therapy director granted 2,306 restricted shares

Minan Peter Francis reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Minan Peter Francis reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Peter Francis Minan received a grant of 2,306 shares of common stock as a stock award, with a corrected transaction price of $0.00 per share. This award was issued as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan.

Following the grant, he holds 2,431 shares directly. The restrictions on these 2,306 shares lapse in stages: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, provided he is a director on those dates.

Insider Trade Summary

Grant/Award: 2,306 shares

Grant/Award 1 txn

Insider Minan Peter Francis

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,306	$0.00	$0.00

Holdings After Transaction: Common Stock — 2,431 shares (Direct)

Footnotes (2)

1. F1. 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.
2. F2. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Key Figures

Restricted stock grant: 2,306 shares Transaction price: $0.00 per share Post-transaction holdings: 2,431 shares +3 more

6 metrics

Restricted stock grant 2,306 shares Restricted common stock awarded to director on May 19, 2026

Transaction price $0.00 per share Corrected award price for the 2,306 restricted shares

Post-transaction holdings 2,431 shares Total common shares held directly after the award

Vesting tranche 1 1,153 shares Restrictions lapse on August 20, 2026 if still a director

Vesting tranche 2 576 shares Restrictions lapse on November 20, 2026 if still a director

Vesting tranche 3 577 shares Restrictions lapse on March 6, 2027 if still a director

Key Terms

restricted stock, Amended and Restated 2003 Stock Incentive Plan, Form 4/A, director

4 terms

restricted stock financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Amended and Restated 2003 Stock Incentive Plan financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Form 4/A regulatory

"INSIDER FILING DATA (Form 4/A):"

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

director financial

"if he is a director of the Company on those dates."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did USPH director Peter Francis Minan report on this Form 4/A?

Peter Francis Minan reported receiving 2,306 shares of U.S. Physical Therapy common stock as a restricted stock award. The award was granted at a transaction price of $0.00 per share under the company’s Amended and Restated 2003 Stock Incentive Plan.

How many USPH shares does Peter Francis Minan hold after this restricted stock grant?

After the restricted stock grant, Peter Francis Minan holds 2,431 shares of U.S. Physical Therapy common stock directly. This total includes the 2,306 restricted shares granted as part of the award reported in the amended Form 4 filing.

What is the vesting schedule for the 2,306 restricted USPH shares granted to Minan?

The 2,306 restricted shares vest in three tranches if he remains a director: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, according to the footnote disclosure.

Why was the transaction price corrected to $0.00 in Peter Minan’s USPH Form 4/A?

The amended filing states the transaction price should have been reported as $0.00, not $61.61. This clarifies that the 2,306 restricted shares were granted as a stock award rather than purchased in an open-market transaction.

Under which plan were Peter Minan’s restricted USPH shares granted?

The 2,306 restricted shares were granted under the Company Amended and Restated 2003 Stock Incentive Plan. This plan provides equity-based compensation, and the restrictions on these shares lapse over time while he continues serving as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 04:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Minan Peter Francis

(Last) (First) (Middle)

1300 W SAM HOUSTON PKWAY S, SUITE 300

(Street)

HOUSTON TEXAS 77042

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/20/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		2,306	A	$0.00(1)	2,431(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.

2. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Remarks:

This Form 4/A amends the Form 4 originally filed on May 20, 2026, solely to correct the transaction price reported in Column 4 of Table I. The transaction price was incorrectly reported as $61.61 per share and is corrected herein to $0.00 per share. No other changes are being made to the original filing.

	/s/ Kate Venturina, as attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)